http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 29 May 2026 16:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Lifeward+Ltd.++++++++++++++++++++++++/26575046.html si-local-file:///var/storage/secattach/20260529/26575046.html http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Lifeward+Ltd.++++++++++++++++++++++++/26575046.html Fri, 29 May 2026 16:06:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Lifeward+Ltd.++++++++++++++++++++++++/26575046.html si-local-file:///var/storage/secattach/20260529/26575046.html http://www.streetinsider.com/SEC+Filings/Form++SD+++++++++Lifeward+Ltd.++++++++++++++++++++++++/26575046.html Fri, 29 May 2026 16:06:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lifeward+Ltd.++++++++++++++++++++++++/26529350.html si-local-file:///var/storage/secattach/20260520/26529350.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lifeward+Ltd.++++++++++++++++++++++++/26529350.html Wed, 20 May 2026 17:01:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lifeward+Ltd.++++++++++++++++++++++++/26529350.html si-local-file:///var/storage/secattach/20260520/26529350.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Lifeward+Ltd.++++++++++++++++++++++++/26529350.html Wed, 20 May 2026 17:01:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Lifeward+Ltd.+++++++++++++For%3A+Mar+31/26528753.html si-local-file:///var/storage/secattach/20260520/26528753.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Lifeward+Ltd.+++++++++++++For%3A+Mar+31/26528753.html Wed, 20 May 2026 16:25:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Lifeward+Ltd.+++++++++++++For%3A+Mar+31/26528753.html si-local-file:///var/storage/secattach/20260520/26528753.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Lifeward+Ltd.+++++++++++++For%3A+Mar+31/26528753.html Wed, 20 May 2026 16:25:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525265.html si-local-file:///var/storage/secattach/20260520/26525265.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525265.html Wed, 20 May 2026 08:16:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525265.html si-local-file:///var/storage/secattach/20260520/26525265.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525265.html Wed, 20 May 2026 08:16:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525251.html si-local-file:///var/storage/secattach/20260520/26525251.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525251.html Wed, 20 May 2026 08:14:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525251.html si-local-file:///var/storage/secattach/20260520/26525251.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+May+01++Filed+by%3A+Rose+Keith+Dale/26525251.html Wed, 20 May 2026 08:14:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+May+18/26518032.html si-local-file:///var/storage/secattach/20260519/26518032.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+May+18/26518032.html Tue, 19 May 2026 08:37:00 -0400 LFWD O.13805217 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+May+18/26518032.html si-local-file:///var/storage/secattach/20260519/26518032.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+May+18/26518032.html Tue, 19 May 2026 08:37:00 -0400 LFWD O.13805217 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html <p>Lifeward Ltd. (NASDAQ: LFWD) appointed Dr. Keith D. Rose as chief medical officer, promoting him from his previous role as vice president of medical affairs and medical director of neurosciences.</p> <p>Rose joined the biomedical innovation company in 2023 and has led medical affairs strategy, payer engagement initiatives, and clinical education efforts. He brings more than 30 years of experience in rehabilitation medicine, neuroscience, and medical affairs across clinical practice and the medical technology and biopharmaceutical industries.</p> <p>Before joining Lifeward, Rose held senior medical affairs positions at Biocodex, Novocure, Ipsen Bioscience, Jazz Pharmaceuticals, and Indivior. He previously worked as a practicing physiatrist and http://www.streetinsider.com/Management+Changes/Lifeward+names+Dr.+Keith+Rose+chief+medical+officer/26517568.html Tue, 19 May 2026 08:00:50 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Dr.+Keith+D.+Rose+as+Chief+Medical+Officer+to+Support+Expansion+of+Neurorehabilitation+Portfolio+and+Advance+Biomed+Platform/26517538.html <p align="center"><em>Veteran physician</em><em>, </em><em>medical affairs</em><em> and clinical research</em><em> leader</em> <em>brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience</em><em>, </em><em>mobility technologies</em><em>, and </em><em>metabolic disease</em></p> <p align="center"><em>Promotion reflects Lifeward’s continued investment in clinical innovation, evidence generation</em><em>,</em><em> and patient outcomes across its expanding </em><em>med-tech </em><em>rehabilitation </em><em>and biomed </em><em>technology portfolio</em></p> <p align="justify">HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=K8wsqUj2eILXfaZK-o6mtOydg5AVAeyZ0C7JJsJPuXaVHzMg2IjbAHQYfM0yG22v3TfpcpF5wfqH7sQrpe06nA==" rel="nofollow" target="_blank">Lifeward</a><a target="_blank" href="https://www.globenewswire.com/Tracker?data=2LdVZpgMk69hvYqV1U1WwQnAK9Cqlk9-9_tTm9KMr0eNV41FgNzcW2YltXCi4KkNPeO4aDmV1lbF8Lg73VHKyQ==" rel="nofollow" target="_blank"> Ltd</a>. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Dr.+Keith+D.+Rose+as+Chief+Medical+Officer+to+Support+Expansion+of+Neurorehabilitation+Portfolio+and+Advance+Biomed+Platform/26517538.html Tue, 19 May 2026 08:00:00 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Dr.+Keith+D.+Rose+as+Chief+Medical+Officer+to+Support+Expansion+of+Neurorehabilitation+Portfolio+and+Advance+Biomed+Platform/26517538.html <p align="center"><em>Veteran physician</em><em>, </em><em>medical affairs</em><em> and clinical research</em><em> leader</em> <em>brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience</em><em>, </em><em>mobility technologies</em><em>, and </em><em>metabolic disease</em></p> <p align="center"><em>Promotion reflects Lifeward’s continued investment in clinical innovation, evidence generation</em><em>,</em><em> and patient outcomes across its expanding </em><em>med-tech </em><em>rehabilitation </em><em>and biomed </em><em>technology portfolio</em></p> <p align="justify">HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=K8wsqUj2eILXfaZK-o6mtOydg5AVAeyZ0C7JJsJPuXaVHzMg2IjbAHQYfM0yG22v3TfpcpF5wfqH7sQrpe06nA==" rel="nofollow" target="_blank">Lifeward</a><a target="_blank" href="https://www.globenewswire.com/Tracker?data=2LdVZpgMk69hvYqV1U1WwQnAK9Cqlk9-9_tTm9KMr0eNV41FgNzcW2YltXCi4KkNPeO4aDmV1lbF8Lg73VHKyQ==" rel="nofollow" target="_blank"> Ltd</a>. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Dr.+Keith+D.+Rose+as+Chief+Medical+Officer+to+Support+Expansion+of+Neurorehabilitation+Portfolio+and+Advance+Biomed+Platform/26517538.html Tue, 19 May 2026 08:00:00 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287 http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Dr.+Keith+D.+Rose+as+Chief+Medical+Officer+to+Support+Expansion+of+Neurorehabilitation+Portfolio+and+Advance+Biomed+Platform/26517538.html <p align="center"><em>Veteran physician</em><em>, </em><em>medical affairs</em><em> and clinical research</em><em> leader</em> <em>brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience</em><em>, </em><em>mobility technologies</em><em>, and </em><em>metabolic disease</em></p> <p align="center"><em>Promotion reflects Lifeward’s continued investment in clinical innovation, evidence generation</em><em>,</em><em> and patient outcomes across its expanding </em><em>med-tech </em><em>rehabilitation </em><em>and biomed </em><em>technology portfolio</em></p> <p align="justify">HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=K8wsqUj2eILXfaZK-o6mtOydg5AVAeyZ0C7JJsJPuXaVHzMg2IjbAHQYfM0yG22v3TfpcpF5wfqH7sQrpe06nA==" rel="nofollow" target="_blank">Lifeward</a><a target="_blank" href="https://www.globenewswire.com/Tracker?data=2LdVZpgMk69hvYqV1U1WwQnAK9Cqlk9-9_tTm9KMr0eNV41FgNzcW2YltXCi4KkNPeO4aDmV1lbF8Lg73VHKyQ==" rel="nofollow" target="_blank"> Ltd</a>. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Dr.+Keith+D.+Rose+as+Chief+Medical+Officer+to+Support+Expansion+of+Neurorehabilitation+Portfolio+and+Advance+Biomed+Platform/26517538.html Tue, 19 May 2026 08:00:00 -0400 A.08065483 A.33276371 A.38029192 A.40866182 LFWD O.00385117 O.05851094 O.13805217 O.49279143 O.49824287